229 related articles for article (PubMed ID: 7972319)
1. Inhibition of K+ channels and stimulation of insulin secretion by the sulfonylurea, glimepiride, in relation to its membrane binding in pancreatic islets.
Schwanstecher M; Mnner K; Panten U
Pharmacology; 1994 Aug; 49(2):105-11. PubMed ID: 7972319
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at beta-cells.
Kramer W; Müller G; Geisen K
Horm Metab Res; 1996 Sep; 28(9):464-8. PubMed ID: 8911984
[TBL] [Abstract][Full Text] [Related]
3. Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets.
Panten U; Burgfeld J; Goerke F; Rennicke M; Schwanstecher M; Wallasch A; Zünkler BJ; Lenzen S
Biochem Pharmacol; 1989 Apr; 38(8):1217-29. PubMed ID: 2650685
[TBL] [Abstract][Full Text] [Related]
4. The molecular interaction of sulfonylureas with beta-cell ATP-sensitive K(+)-channels.
Kramer W; Müller G; Girbig F; Gutjahr U; Kowalewski S; Hartz D; Summ HD
Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S67-80. PubMed ID: 8529521
[TBL] [Abstract][Full Text] [Related]
5. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
Clark HE; Matthews DR
Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic beta-cell K(ATP) channel activity and membrane-binding studies with nateglinide: A comparison with sulfonylureas and repaglinide.
Hu S; Wang S; Fanelli B; Bell PA; Dunning BE; Geisse S; Schmitz R; Boettcher BR
J Pharmacol Exp Ther; 2000 May; 293(2):444-52. PubMed ID: 10773014
[TBL] [Abstract][Full Text] [Related]
7. Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. II. Photoaffinity labeling of a 65 kDa protein by [3H]glimepiride.
Kramer W; Müller G; Girbig F; Gutjahr U; Kowalewski S; Hartz D; Summ HD
Biochim Biophys Acta; 1994 May; 1191(2):278-90. PubMed ID: 8172913
[TBL] [Abstract][Full Text] [Related]
8. Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. I. Binding characteristics.
Müller G; Hartz D; Pünter J; Okonomopulos R; Kramer W
Biochim Biophys Acta; 1994 May; 1191(2):267-77. PubMed ID: 8172912
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes.
Fuhlendorff J; Rorsman P; Kofod H; Brand CL; Rolin B; MacKay P; Shymko R; Carr RD
Diabetes; 1998 Mar; 47(3):345-51. PubMed ID: 9519738
[TBL] [Abstract][Full Text] [Related]
10. Antidiabetic sulfonylurea stimulates insulin secretion independently of plasma membrane KATP channels.
Geng X; Li L; Bottino R; Balamurugan AN; Bertera S; Densmore E; Su A; Chang Y; Trucco M; Drain P
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E293-301. PubMed ID: 17405830
[TBL] [Abstract][Full Text] [Related]
11. Sulfonylurea binding to a low-affinity site inhibits the Na/K-ATPase and the KATP channel in insulin-secreting cells.
Ribalet B; Mirell CJ; Johnson DG; Levin SR
J Gen Physiol; 1996 Feb; 107(2):231-41. PubMed ID: 8833343
[TBL] [Abstract][Full Text] [Related]
12. Insulin secretion and its modulation by antiarrhythmic and sulfonylurea drugs.
Horie M; Ishida-Takahashi A; Ai T; Nishimoto T; Tsuura Y; Ishida H; Seino Y; Sasayama S
Cardiovasc Res; 1997 Apr; 34(1):69-72. PubMed ID: 9217874
[TBL] [Abstract][Full Text] [Related]
13. Glucose regulation of insulin secretion independent of the opening or closure of adenosine triphosphate-sensitive K+ channels in beta cells.
Sato Y; Anello M; Henquin JC
Endocrinology; 1999 May; 140(5):2252-7. PubMed ID: 10218978
[TBL] [Abstract][Full Text] [Related]
14. Effects of the hypoglycaemic drugs repaglinide and glibenclamide on ATP-sensitive potassium-channels and cytosolic calcium levels in beta TC3 cells and rat pancreatic beta cells.
Gromada J; Dissing S; Kofod H; Frøkjaer-Jensen J
Diabetologia; 1995 Sep; 38(9):1025-32. PubMed ID: 8591815
[TBL] [Abstract][Full Text] [Related]
15. Adenine nucleotide-induced inhibition of binding of sulphonylureas to their receptor in pancreatic islets.
Schwanstecher M; Löser S; Brandt C; Scheffer K; Rosenberger F; Panten U
Br J Pharmacol; 1992 Mar; 105(3):531-4. PubMed ID: 1628141
[TBL] [Abstract][Full Text] [Related]
16. A novel enhancer of insulinotrophic action by high glucose (JTT-608) stimulates insulin secretion from pancreatic beta-cells via a new cellular mechanism.
Itabashi N; Okada K; Muto S; Fujita N; Ohta T; Miyazaki Ji ; Asano Y; Saito T
J Pharmacol Exp Ther; 2001 Jun; 297(3):953-60. PubMed ID: 11356916
[TBL] [Abstract][Full Text] [Related]
17. Chronic antidiabetic sulfonylureas in vivo: reversible effects on mouse pancreatic beta-cells.
Remedi MS; Nichols CG
PLoS Med; 2008 Oct; 5(10):e206. PubMed ID: 18959471
[TBL] [Abstract][Full Text] [Related]
18. Characterization of sulfonylurea receptors in isolated human pancreatic islets.
Giannaccini G; Lupi R; Trincavelli ML; Navalesi R; Betti L; Marchetti P; Lucacchini A; Del Guerra S; Martini C
J Cell Biochem; 1998 Nov; 71(2):182-8. PubMed ID: 9779817
[TBL] [Abstract][Full Text] [Related]
19. Cationic and secretory effects of glimepiride and glibenclamide in perifused rat islets.
Lebrun P; Malaisse WJ
Pharmacol Toxicol; 1992 May; 70(5 Pt 1):357-60. PubMed ID: 1608924
[TBL] [Abstract][Full Text] [Related]
20. Uptake of glibornuride by microdissected pancreatic islets.
Täljedal IB
Horm Res; 1974; 5(4):211-6. PubMed ID: 4210148
[No Abstract] [Full Text] [Related]
[Next] [New Search]
